A correction to the PURE cohort study clarifies data presentation in the appendix regarding life-course trajectories of walking limitation and mortality risk across 25 countries spanning different income levels. The correction ensures accuracy in how modifiable risk factors associated with mobility decline and longevity outcomes are reported.
Key Points
- Appendix data corrected for walking limitation trajectories
- Modifiable risk factors tracked across 25 countries
- Income-level variations in mortality and mobility outcomes
Longevity Analysis
Walking capacity serves as a measurable indicator of functional reserve and systemic health status across diverse populations. Corrections to large prospective cohort data improve the reliability of risk factor identification—essential for distinguishing which lifestyle and physiological factors genuinely predict mobility decline versus mortality in different economic contexts. Accurate characterization of these trajectories strengthens the evidence base for intervention strategies targeting preservation of physical function, a core predictor of healthspan independent of chronological age.
Original published by The Lancet Healthy Longevity.